Published in Am J Pathol on March 01, 1998
NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest (2001) 3.34
Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler Thromb Vasc Biol (2010) 1.44
Role of carbon monoxide in cardiovascular function. J Cell Mol Med (2006) 1.41
Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal (2010) 1.41
Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1. Circ Res (2011) 1.36
Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am J Pathol (2008) 1.26
Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med (2009) 1.24
Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Front Pharmacol (2012) 1.17
Induction of the cytoprotective enzyme heme oxygenase-1 by statins is enhanced in vascular endothelium exposed to laminar shear stress and impaired by disturbed flow. J Biol Chem (2009) 1.16
Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival. Cardiovasc Res (2007) 1.11
Heme oxygenase-1 in inflammation and cardiovascular disease. Am J Cardiovasc Dis (2011) 1.10
Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochem Biophys Res Commun (2007) 1.09
Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis. Clin Exp Immunol (2005) 1.07
Induction of HO-1 in tissue macrophages and monocytes in fatal falciparum malaria and sepsis. Malar J (2003) 1.05
Targeting heme oxygenase-1 in vascular disease. Curr Drug Targets (2010) 1.05
New insights into intracellular locations and functions of heme oxygenase-1. Antioxid Redox Signal (2014) 0.97
Interleukin-19 (IL-19) induces heme oxygenase-1 (HO-1) expression and decreases reactive oxygen species in human vascular smooth muscle cells. J Biol Chem (2011) 0.96
Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival. Am J Physiol Cell Physiol (2009) 0.96
Genes and abdominal aortic aneurysm. Ann Vasc Surg (2010) 0.95
Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J Am Soc Nephrol (2009) 0.90
Genetic variants of the promoter of the heme oxygenase-1 gene and their influence on cardiovascular disease (the Ludwigshafen Risk and Cardiovascular Health study). BMC Med Genet (2009) 0.90
Hypochlorite-modified high-density lipoprotein promotes induction of HO-1 in endothelial cells via activation of p42/44 MAPK and zinc finger transcription factor Egr-1. Arch Biochem Biophys (2011) 0.88
Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura. Rheumatol Int (2009) 0.87
Short (GT) ( n ) repeats in heme oxygenase-1 gene promoter are associated with lower risk of coronary heart disease in subjects with high levels of oxidative stress. Cell Stress Chaperones (2011) 0.86
Immunohistochemical analysis of heme oxygenase-1 in preneoplastic and neoplastic lesions during chemical hepatocarcinogenesis. Int J Exp Pathol (2004) 0.85
Heme Oxygenases in Cardiovascular Health and Disease. Physiol Rev (2016) 0.82
Haeme oxygenase signalling pathway: implications for cardiovascular disease. Eur Heart J (2015) 0.81
Ectopic overexpression of haem oxygenase-1 protects kidneys from carboplatin-mediated apoptosis. Br J Pharmacol (2011) 0.79
Heme oxygenase-1 expression in premature and mature neonates during the first week of life. Eur J Pediatr (2007) 0.78
Heme oxygenase 1 expression in young uremic patients on hemodialysis. Pediatr Nephrol (2004) 0.76
Homeostatic response under carcinogen withdrawal, heme oxygenase 1 expression and cell cycle association. BMC Cancer (2006) 0.76
Zinc oxide nanoparticle-induced atherosclerotic alterations in vitro and in vivo. Int J Nanomedicine (2017) 0.75
Near-infrared autofluorescence induced by intraplaque hemorrhage and heme degradation as marker for high-risk atherosclerotic plaques. Nat Commun (2017) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 27.07
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science (1992) 11.83
Bilirubin is an antioxidant of possible physiological importance. Science (1987) 11.26
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell (1992) 10.97
Carbon monoxide: a putative neural messenger. Science (1993) 5.47
Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem (1992) 4.22
The oxidation hypothesis of atherosclerosis. Lancet (1994) 4.10
Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation (1995) 3.82
Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest (1992) 3.50
Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res (1987) 2.59
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A (1995) 2.41
Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler Thromb (1994) 2.31
Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem (1994) 2.20
Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur J Biochem (1988) 2.16
Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc Natl Acad Sci U S A (1994) 2.13
Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels (1991) 1.98
Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci U S A (1994) 1.85
Oxidative stress resulting from ultraviolet A irradiation of human skin fibroblasts leads to a heme oxygenase-dependent increase in ferritin. J Biol Chem (1993) 1.70
Induction of haem oxygenase as a defence against oxidative stress. Free Radic Res Commun (1990) 1.69
Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest (1995) 1.65
Heme oxygenase does not protect human cells against oxidant stress. J Lab Clin Med (1994) 1.63
Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol (1994) 1.62
Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophys Acta (1994) 1.61
Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol (1996) 1.58
Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest (1997) 1.57
Zinc . protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat. Biochim Biophys Acta (1981) 1.42
Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc Natl Acad Sci U S A (1995) 1.41
Transcriptional activation of the heme oxygenase gene by heme and cadmium in mouse hepatoma cells. J Biol Chem (1989) 1.40
Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Feedback regulation by glucocorticoids. Biochem J (1991) 1.40
Cytokine induction of haem oxygenase mRNA in mouse liver. Interleukin 1 transcriptionally activates the haem oxygenase gene. Biochem J (1993) 1.33
Oxidant stress leads to transcriptional activation of the human heme oxygenase gene in cultured skin fibroblasts. Mol Cell Biol (1990) 1.29
Evidence suggesting that the two forms of heme oxygenase are products of different genes. J Biol Chem (1988) 1.29
Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem (1994) 1.25
Multiple elements within the 5' distal enhancer of the mouse heme oxygenase-1 gene mediate induction by heavy metals. J Biol Chem (1994) 1.17
NO., CO and .OH. Endogenous soluble guanylyl cyclase-activating factors. FEBS Lett (1992) 1.17
Heme oxygenase-mediated resistance to oxygen toxicity in hamster fibroblasts. J Biol Chem (1997) 1.17
Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J Biol Chem (1996) 1.14
Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci U S A (1994) 1.09
Bilirubin attenuates radical-mediated damage to serum albumin. FEBS Lett (1993) 1.08
Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest (1996) 1.07
Role of bilirubin as an antioxidant in an ischemia-reperfusion of rat liver and induction of heme oxygenase. Biochem Biophys Res Commun (1996) 1.07
Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidised LDL in cultured vascular smooth muscle cells. FEBS Lett (1995) 1.06
High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis. Arterioscler Thromb (1993) 1.01
Lipid hydroperoxy and hydroxy derivatives in copper-catalyzed oxidation of low density lipoprotein. J Lipid Res (1990) 1.01
Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol (1995) 1.00
Induction of the heme oxygenase gene in human skin fibroblasts by hydrogen peroxide and UVA (365 nm) radiation: evidence for the involvement of the hydroxyl radical. Carcinogenesis (1990) 0.96
Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler Thromb Vasc Biol (1996) 0.95
Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol (1996) 0.91
Nitric oxide and carbon monoxide as possible retrograde messengers in hippocampal long-term potentiation. J Neurobiol (1994) 0.88
Preischemic but not postischemic zinc protoporphyrin treatment reduces infarct size and edema accumulation after temporary focal cerebral ischemia in rats. Stroke (1995) 0.84
Bilirubin is oxidized in rats treated with endotoxin and acts as a physiological antioxidant synergistically with ascorbic acid in vivo. Biochem Biophys Res Commun (1995) 0.82
Neuroprotection against CA1 injury with metalloporphyrins. Neuroreport (1996) 0.80
Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69
Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest (1988) 6.29
Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol (2000) 5.01
Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med (1996) 4.51
YC-1, a novel activator of platelet guanylate cyclase. Blood (1994) 2.38
Chondroblastoma of bone. J Bone Joint Surg Am (2000) 2.33
Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 2.32
Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function. J Hepatol (1995) 2.10
Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol (1995) 1.87
The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (1999) 1.77
A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med (1998) 1.61
Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J (2008) 1.55
Endoscopic injection for the treatment of bleeding ulcers: local tamponade or drug effect? Endoscopy (1994) 1.54
A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2 diabetes: studies in a new mouse model. Diabetologia (2008) 1.52
A new study of bacterial motion: superconducting quantum interference device microscopy of magnetotactic bacteria. Biophys J (1999) 1.51
Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Gastroenterology (1992) 1.45
Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. Proc Natl Acad Sci U S A (1998) 1.44
Evidence against a role for endotoxin in the hyperdynamic circulation of rats with prehepatic portal hypertension. J Hepatol (1999) 1.43
Peritoneal inclusion cysts and their relationship to the ovaries: evaluation with sonography. Radiology (1997) 1.43
Sequential variceal pressure measurement by endoscopic needle puncture during maintenance sclerotherapy: the correlation between variceal pressure and variceal rebleeding. J Hepatol (1998) 1.43
Structural and functional roles of asparagine 175 in the cysteine protease papain. J Biol Chem (1995) 1.40
YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol (1995) 1.39
Induction of plasma protein secretion in a newly established human hepatoma cell line. Mol Cell Biol (1983) 1.39
Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells. Br J Cancer (2009) 1.38
Serum uric acid levels in patients with cirrhosis: a reevaluation. J Clin Gastroenterol (1999) 1.37
Enzymic and immunochemical properties of lysozyme. XVI. A novel synthetic approach to an antigenic reactive site by direct linkage of the relevant conformationally adjacent residues constituting the site. Biochim Biophys Acta (1976) 1.37
Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib. Leukemia (2008) 1.36
Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice. Br J Cancer (1983) 1.33
Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology (1999) 1.33
Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol (1999) 1.32
Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology (1995) 1.28
YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice. Eur J Pharmacol (1997) 1.25
Terminology and classification of congenital vascular malformations. Phlebology (2007) 1.25
Bipolar clavicular injury. Med J Malaysia (2003) 1.24
Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology (1995) 1.21
First light-emitting neutral molecular rectangles. Inorg Chem (2000) 1.19
Concentric tracheal and subglottic stenosis. Management using the Nd-YAG laser for mucosal sparing followed by gentle dilatation. Chest (1993) 1.18
Characterization of BMS-911543, a functionally selective small-molecule inhibitor of JAK2. Leukemia (2011) 1.18
Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleeding. Gut (1999) 1.17
Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft. Cancer Chemother Pharmacol (2005) 1.17
Early or delayed endoscopy for patients with peptic ulcer bleeding. A prospective randomized study. J Clin Gastroenterol (1996) 1.14
Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol (1997) 1.14
Altered antigenicity of 'a' determinant variants of hepatitis B virus. J Gen Virol (1997) 1.13
Heat probe thermocoagulation and pure alcohol injection in massive peptic ulcer haemorrhage: a prospective, randomised controlled trial. Gut (1990) 1.13
Clinical implications of the white nipple sign and its role in the diagnosis of esophageal variceal hemorrhage. Am J Gastroenterol (1996) 1.12
Correlation of cytogenetic results with immunophenotype, genotype, clinical features, and ras mutation in acute myeloid leukemia. A study of 235 Chinese patients in Taiwan. Cancer Genet Cytogenet (1995) 1.10
Endoscopic injection for the arrest of peptic ulcer hemorrhage: final results of a prospective, randomized comparative trial. Gastrointest Endosc (1993) 1.10
Blood rheology: effect of fibrinogen deduced by addition. Circ Res (1966) 1.09
Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. Br J Haematol (2001) 1.09
Accuracy of capnography in nonintubated surgical patients. Chest (1992) 1.08
Spider angiomas in patients with liver cirrhosis: role of alcoholism and impaired liver function. Scand J Gastroenterol (1999) 1.08
Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest (1996) 1.07
Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism. Biochem Pharmacol (1983) 1.06
Bacteremia after endoscopic injection of N-butyl-2-cyanoacrylate for gastric variceal bleeding. Gastrointest Endosc (2001) 1.05
Profiles of gonadal development, sex steroids, aromatase activity, and gonadotropin II in the controlled sex change of protandrous black porgy, Acanthopagrus schlegeli Bleeker. Gen Comp Endocrinol (2000) 1.04
Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. Circulation (1999) 1.03
Airway-obstructing supraglottic edema following anesthesia with the head positioned in forced flexion. Anesthesiology (1981) 1.03
Release of arachidonate from diglyceride in human platelets requires the sequential action of a diglyceride lipase and a monoglyceride lipase. Biochem Biophys Res Commun (1981) 1.01
Active transposition in zebrafish. Proc Natl Acad Sci U S A (1996) 1.01
The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol (1998) 1.01
Preclinical antitumor activity of two novel taxanes. Cancer Chemother Pharmacol (2001) 0.99
Hepatic hemodynamic features in patients with esophageal or gastric varices. J Hepatol (1993) 0.99
Utility of lentil lectin affinity of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. J Hepatol (1996) 0.98
Clinical courses and predictors for rebleeding in patients with peptic ulcers and non-bleeding visible vessels: a prospective study. Gut (1994) 0.96
Chylous ascites in acute pancreatitis during pregnancy: case report. Chang Gung Med J (2001) 0.96
Resolution into two different forms and study of the properties of phosphatidylinositol-specific phospholipase C from human platelet cytosol. Biochim Biophys Acta (1982) 0.96
Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites. J Gastroenterol Hepatol (1994) 0.96
A prospectively randomized trial of heat probe thermocoagulation versus pure alcohol injection in nonvariceal peptic ulcer hemorrhage. Am J Gastroenterol (1988) 0.96
Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol (1994) 0.95
Enzymic and immunochemical properties of lysozyme--XV. Delineation of the reactive site around the two central disulfides by immunochemical studies of novel synthetic peptides that contain diglycyl bridges instead of disulfides. Immunochemistry (1976) 0.95
Therapeutic endoscopy for Dieulafoy's disease. J Clin Gastroenterol (1989) 0.95
YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway. Br J Pharmacol (2008) 0.95
Pathologic supracondylar fracture due to osteolytic pseudotumor of knee following cementless total knee replacement. J Biomed Mater Res (1998) 0.94
Antitumor agents 210. Synthesis and evaluation of taxoid-epipodophyllotoxin conjugates as novel cytotoxic agents. Bioorg Med Chem (2001) 0.94
Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J Gastroenterol Hepatol (1996) 0.94
Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. J Neurochem (1996) 0.93
Immunochemistry of sperm-whale myoglobin--XXII. Accurate delineation of the single reactive region in sequence 103-120 by immunochemical studies of synthetic peptides: the complete antigenic structure of the protein. Immunochemistry (1975) 0.93
Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy. Leukemia (2012) 0.93
Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors. Am J Med Genet (1998) 0.93
Relationship of portal pressure, anorectal varices and hemorrhoids in cirrhotic patients. J Hepatol (1992) 0.93
Predictive factors for rebleeding in patients with peptic ulcer bleeding after multipolar electrocoagulation: a retrospective analysis. J Clin Gastroenterol (1998) 0.92
Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine. Br J Cancer (1987) 0.92
Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium. Am J Physiol (1992) 0.91
The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma. Cancer (1992) 0.91
Effects of salt concentration on floc characteristics and pollutants removal efficiencies in treatment of seafood wastewater by SBR. Water Sci Technol (2003) 0.91
A longitudinal observational study of preference for elective caesarean section among nulliparous Hong Kong Chinese women. BJOG (2007) 0.91
Establishment of an animal model of hepatic encephalopathy. Zhonghua Yi Xue Za Zhi (Taipei) (2000) 0.90
Sensitivity of physiologically based pharmacokinetic models to variation in model parameters: methylene chloride. Risk Anal (1994) 0.90
Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience. J Clin Endocrinol Metab (1997) 0.90
Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis (1998) 0.90
Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosis. J Hepatol (1989) 0.90
Physiologic load-bearing characteristics of autografts, allografts, and polymer-based scaffolds in a critical sized segmental defect of long bone: an experimental study. Int J Nanomedicine (2013) 0.89
Klebsiella pneumoniae bacteremia: analysis of 100 episodes. J Formos Med Assoc (1990) 0.89
A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol (1992) 0.88
Increased expression of Gs(alpha) enhances activation of the adenylyl cyclase signal transduction cascade. Mol Endocrinol (1997) 0.88
The rebleeding course and long-term outcome of esophageal variceal hemorrhage after ligation: comparison with sclerotherapy. Scand J Gastroenterol (1999) 0.88
Synthesis and antitumor activity of novel C-7 paclitaxel ethers: discovery of BMS-184476. J Med Chem (2001) 0.88